Kelun, Merck tout ADC as potential first-line treatment in lung cancer
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
Body unavailable. Use the original source.
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.